The U.S. Department of Justice has filed a lawsuit against Walgreens Boots Alliance (NASDAQ:WBA) in Illinois federal court for dispensing millions of unlawful prescriptions over a 12-year period, driving Walgreens (NASDAQ:WBA) shares sharply lower in after-hours trading.
According to the DOJ lawsuit, Walgreens (WBA) and its subsidiaries, filled prescriptions – many of which were for controlled substances that lacked a legitimate medical purpose – with clear red flags without taking the time to confirm their validity in violation of the Controlled Substances Act (“CSA”).